Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

2.4 C
Cheshire
Friday, April 11, 2025
HomeWellbeing

Wellbeing

spot_imgspot_img

MUM-TREPRENEUR OFFERS JUICY INVESTMENT OPPORTUNITY WITH BUSINESS SALE

A mum of three from Cheshire who launched her own juice cleanse business during lockdown is looking to sell her zesty company to focus...

Esteve Enters The American Pain Market With Its New Medicine

The Spanish company Esteve has obtained approval from the American FDA for its new treatment, Seglentis, indicated for the treatment of acute pain in...

Almirall Launches Its Medicine With A Potential Of 250 Million In Europe

Almirall begins marketing its new therapeutic promise in Europe. Klisyri, the innovation of the Catalan pharmaceutical for topical actinic keratosis can be prescribed both...

Novavax Vaccine Promises 100% Efficacy Against Moderate Or Severe Disease

The American biotechnology company Novavax with its partner, Serum Institute of India, have announced the regulatory submission to the World Health Organization (WHO) for...

Subscribe

- Never miss a story with notifications

Must read

spot_imgspot_img